GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of MCL1 with inhibitor

Analyse Co-crystal structure of MCL1 with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6O6G
Type
protein
Length
145 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
LOJ
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 80% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInduced myeloid leukemia cell differentiation protein mcl- 1protein14580% helix, 0% strandQ07820

Ligands and binding sites

  • LOJ · (3S)-5-(cyclobutylmethyl)-3-(2,4-dichlorophenyl)-2,3,4, 5-tetrahydro-1,5-benzoxazepine-7-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11510.580.8217LOJ

Compared structures

  • 6O6G · Co-crystal structure of Mcl1 with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.